MorphImmune Employee Directory
Biotechnology ResearchIndiana, United States0-1 Employees
MorphImmune is a preclinical biotechnology company focused on developing targeted cancer therapies. Its proprietary Targeted Effector platform aims to selectively deliver payloads to diseased cells, reducing collateral toxicity and enhancing the activity of known effector molecules to improve patient outcomes. Based in Lafayette, Indiana, the company operates in the biotechnology research sector as a small, early-stage entity. On June 29, 2023, MorphImmune merged with Immunome to form a combined company pursuing the development of targeted cancer therapies.